Pharmacokinetics and tissue distribution of long circulating liposomal formulation of 2',3'-dideoxyinosine

International Journal of Pharmaceutics

Volumn 152, Issue 1, 1997, Pages 89-97

  Dipali, Satish R ^a   Lin, Yuh Jing ^a   Ravis, William R ^a   Betageri, Guru V ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Dideoxyinosine; Liposome; Long circulating; Multilamellar; Pharmacokinetics; Unilamellar

Indexed keywords

DIDANOSINE; LIPOSOME;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG TISSUE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

EID: 0030943130     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00070-7     Document Type: Article

References (36)

1. Allen, T.M., Hansen, C., Martin, F., Redemann, C. and Yau-Young, A., Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta, 1066 (1991) 29-36.
2. Allen, T.M. and Hansen, C., Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim. Biophys. Acta, 1068 (1991) 133-141.
3. Allen, T.M., In Gregoriadis, G. (Ed.), Liposomes as drug carriers, Wiley, New York, 1988, pp. 37-50.
4. Allen, T.M. and Chonn, A., Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett., 223 (1987) 42-46.
5. Barboza, A., Castro, B. A., Whalen, M., Moore, C.C.D., Parkin, J.S., Miller, W.L., Gonzalez-Scarano, F. and Levy, J.A., Infection of cultured human adrenal cells by different strains of HIV. AIDS, 12 (1992) 1437-1443.
6. Chayt, K.J., Harper, M.E., Marselle, L.M., Lewin, E.B., Rose, R.M., Oleske, J.M., Epstein, L.G., Wong-Staal, F. and Gallo, R.C., Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. J. Am. Med. Assoc., 256 (1986) 2356-2359.
7. Connolly, K.J., Allan, J.D., Fitch, H., Jackson-Pope, L., McLaren, C., Canetta, R. and Groopman, J.E., Phase I study of 2′-3′-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine. Am. J. Med., 91 (1991) 471-478.
8. Desormeaux, A., Harvie, P., Perron, S., Makabi-Panzu, B., Beauchamp, D., Tremblay, M., Poulin, L. and Bergeron, M.G., Antiviral efficacy, intracellular uptake and pharmacokinetics of free and liposome-encapsulated 2′,3′-dideoxyinosine. AIDS, 8 (1994) 1545-1553.
9. Dipali, S.R., Singh, M. and Betageri, G.V., Long circulating liposomes of 2′,3′-dideoxyinosine: Formulation and stability. Drug Del., 1 (1996) 279-287.
10. Gabizon, A. and Papahadjopoulos, D., Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA, 85 (1988) 6949-6953.
11. Gay, B., Cardot, J., Schnell, C., Hoogerest, P. and Gygax, D., Comparative pharmacokinetics of free muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) and liposomal MTP-PE. J. Pharm. Sci., 82 (1993) 997-1001.
12. Gill, P.S., Rarick, M., Brynes, R.K., Causey, D., Loureiro, C. and Levine, A.M., Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med., 107 (1987) 502-505.
13. Groopman, J.E., Zidovudine intolerance. Rev. Infect. Dis., 12 (1990) S500-S506.
14. Kahn, J.O., Lagakos, S.W., Richman D.D., Cross, A., Pettinelli, C., Liou, S.H., Brown, M., Volberding, P.A., Crumpacker, C.S. and Beall, G., A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N. Engl. J. Med., 327 (1992) 581-587.
15. Kamali, F., Clinical pharmacology of zidovudine and other 2′,3′-dideoxynucleoside analogues. Clin. Investig., 71 (1993) 392-405.
16. Klecker, R.W., Collins, J.M., Yarchoan, R., Thomas, R., McAtee, N., Broder, S. and Myers, S., Pharmacokinetics of 2′,3′-dideoxycytidine in patients with AIDS and related disorders. J. Clin. Phar., 28 (1988) 837-842.
17. Klibanov, A.L., Maruyama, K., Beckerley, A.M., Torchilin, V. and Huang, L., Activity of amphipathic poly (ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta, 1062 (1991) 142-148.
18. Klibanov, A.L., Maruyama, K., Torchilin, V.P. and Huang, L., Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett., 268 (1990) 235-237.
19. Lasic, D.D., Woodle, M.C. and Papahadjopoulos, D., On the molecular molecular mechanism of steric stabilization of liposomes in biological fluids. J. Lip. Res., 2 (1992) 335-353.
20. Lipsky, J.J., Zalcitabine and didanosine. Lancet, 341 (1993) 30-32.
21. Litzinger, D.C., Buiting, A.M., Rooijen, N.C. and Huang, L., Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly (ethylene glycol)-containing liposomes. Biochim. Biophys. Acta, 1190 (1994) 99-107.
22. McGowan, J.J., Tomaszewski, J.E., Cradock, J., Hoth, D., Grieshaber, C.K., Broder, S. and Mitsuya, H., Overview of the preclinical development of an antiretroviral drug, 2′,3′-dideoxyinosine. Rev. Inf. Dis., 12(5) (1990) S513-S520.
23. Mitsuya, H., Weinhold, K.J., Furman, P.A., St. Clair, M.H., Lehrman, S.N., Gallo, R.C., Bolognesi, D., Barry, D.W. and Broder, S., 3′-Azido-3′-dideoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in virto. Proc. Natl. Acad. Sci. USA., 82 (1985) 7096-7100.
24. Mitsuya, H. and Broder, S., Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc. Natl. Acad. Sci. USA, 83 (1986) 1911-1915.
25. Moghimi, S.M. and Patel, H.M., Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. FEBS Lett., 233 (1988) 143-147.
26. Moghimi, S.M. and Patel, H.M., Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. Biochim. Biophys. Acta, 984 (1989) 379-383.
27. 1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett., 284 (1991) 263-266.
28. Rahman, Y.E., Cerny, E.A., Patel, K.R., Lau, E.H. and Wright, B.J., Differential uptake of liposomes varying in size and lipid composition by parenchymal and kuffer cells of mouse liver. Life Sci., 31 (1982) 2061-2071.
29. Ray, G. and Murrill, E., Determination of 2′,3′-dideoxyinosine in plasma by high performance liquid chromatography. Anal. Letters, 20 (1987) 1815-1838.
30. Ray, G.F., Mason, W.D. and Badr, M.Z., Pharmacokinetics of the anti-AIDS drug 2',3'-dideoxyinosine in the rat. Drug Metab. Disp., 18 (1990) 654-658.
31. Roerdink, E., Dijkstr, J., Hartman, G., Bolscher, B. and Scherphof, G., The involvement of parenchymal, kupffer and endothelial liver cells in the hepatic uptake of intra-venously injected liposomes. Effects of lanthanum and gadolinium salts. Biochim. Biophys. Acta, 677 (1981) 79-89.
32. Siegal, T., Doxorubicin encapsulated in long-circulating liposomes in an experimental brain tumor model: Tissue distribution and efficacy studies. In Liposomes in drug delivery, Nineties and beyond, London, 1993.
33. Sunamoto, J. and Iwamoto, K., Proteins-coated and polysaccharide-coated liposomes as drug carriers. Crit. Rev. Ther. Drug Carrier Systems., 2 (1986) 117-136.
34. Torchilin, V.P., Berdichersky, V.R., Barsukor, A.A. and Smirnov, V.N., Coating liposomes with proteins decreases their capture by macrophages. FEBS Lett., III (1980) 184-188.
35. Wiley, C.A., Schrier, R.D., Denaro, F.J., Nelson, J.A., Lampert, P.W. and Oldstone, M.B.A., Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J. Neuropathol. Exp. Neurol., 45 (1986) 127-139.
36. Yarchoan, R., Mitsuya, H., Myers, C.E. and Broder, S.N., Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. N. Engl. J. Med., 321 (1989) 726-738.